Drug Channels

MAY 21, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook This event will be broadcast live on Friday, June 21, 2024, from 12:00 p.m. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 52

Pharmacy Drugs Pharmaceuticals Marketing 52

Drug Channels

JUNE 12, 2024

The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

MARCH 12, 2024

Pharmacies and Pharmacy Benefit Managers. How will the most consequential change in federal drug pricing policy affect the largest pharmacies and PBMs? Find out at my upcoming live video webinar, Drug Channel Implications of the Inflation Reduction Act , on April 5, 2024, from 12:00 p.m. For 2023, DCI estimates that U.S.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

JUNE 18, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. billion figure was roughly accurate for the AllianceRx Walgreens Pharmacy business. Consequently, its market share is closer to 10%, compared with the 3% that we reported.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Hospitals 52

Drug Channels

APRIL 2, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. For more on acquisition cost reimbursement for pharmacies, see Sections 8.4. Pharmacies and Pharmacy Benefit Managers. and 12.3.4. of our new 2024 Economic Report on U.S.

Pharmacy 75

Pharmacy Drugs 75

Drug Channels

JULY 12, 2022

Despite what you may have heard, pharmacy participation in the 340B Drug Pricing Program continues to thrive. Drug Channels Institute’s latest analysis reveals that an astonishing 32,000 pharmacy locations —more than half of the entire U.S. Is this really what Congress intended when the 340B program was established in 1992?

Pharmacy 98

Pharmacy Marketing Hospitals Drugs 98

Drug Channels

NOVEMBER 15, 2023

In Medicare Part D in 2024: The Seven Largest Companies' Preferred Pharmacy Networks and the Coming Collapse of the PDP Market , I documented how those networks now dominate stand-alone Medicare Part D prescription drug plans (PDPs) and have become a major presence in Medicare Advantage prescription drug (MA-PD) plans. to 1:30 p.m.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

DECEMBER 5, 2023

Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription. The common factor behind these two disparate situations: Pharmaceutical wholesalers’ unusual pricing for brand-name drugs sold to pharmacies, hospitals, and other buyers. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Hospitals Pharmaceuticals 98

Drug Channels

APRIL 4, 2024

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. For updated data on hospital-owned specialty pharmacies, see Chapter 3 of DCI's new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals International 52

Drug Channels

MARCH 27, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. The rise of discount card pricing within pharmacy benefit plans is a positive development. Links below.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

MARCH 25, 2024

Find out during Drug Channel Implications of the Inflation Reduction Act , a new live video webinar with Adam J. Click here to learn more and reserve your spot at our April 5 webinar. What’s ahead for the drug channel? Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Hospitals Drugs 97

Drug Channels

JANUARY 11, 2022

As I have highlighted in previous posts, retail pharmacies are experiencing a period of intense competition that continues to pressure prescription profits. What's more, the pharmacy shakeout is accelerating, as smaller competitors exit and larger companies reduce store count. . d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Drugs 98

Drug Channels

NOVEMBER 9, 2022

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2023. The webinar will be broadcast from the Drug Channels studio in beautiful downtown Philadelphia. The webinar will last 90 minutes to accommodate audience questions.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Biosimilars Drugs 98

Drug Channels

DECEMBER 7, 2022

In yesterday’s post , I highlighted the largest pharmacy chains that will participate in the 2023 Medicare Part D prescription drug plans (PDP). What's more, plans from Aetna, Humana, WellCare, and UnitedHealthcare will not have any independent pharmacies participating via PSAOs as preferred pharmacies. to 1:30 p.m.

Pharmacy 98

Pharmacy Independent Pharmacies Drugs 98

Drug Channels

MAY 22, 2023

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding This event will be broadcast live on Friday, June 23, 2023, from 12:00 p.m. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 97

Pharmacy Drugs Marketing Pharmaceuticals 97

Drug Channels

MARCH 8, 2023

Pharmacies and Pharmacy Benefit Managers. The largest 15 pharmacies accounted for more than 75% of total dispensing revenues from retail, mail, long-term care, and specialty pharmacies. How will GoodRx and Mark Cuban Cost Plus Drug Company affect the pharmacy industry? to 1:30 p.m.

Pharmacy 98

Pharmacy Specialty Pharmacies Marketing Drugs 98

Drug Channels

DECEMBER 6, 2023

Is the world ready for new ways to price pharmacy and pharmacy benefit manager (PBM) services? I commend CVS Health for attempting to address key economic challenges facing the retail pharmacy industry and for tackling the hidden complexities of PBM pricing models. Below you'll find details and links to source documents.

Pharmacy 75

Pharmacy Drugs 75

Drug Channels

MARCH 29, 2022

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBM Industry Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. Pharmacies and Pharmacy Benefit Managers. to 1:30 p.m.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Marketing Drugs 97

Drug Channels

JULY 5, 2022

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. This event will be broadcast live on July 29, 2022 , from 12:00 p.m. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Marketing 98

Drug Channels

JUNE 17, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Three is still the magic number for pharmacy benefit managers (PBMs). Click here to see the original post from April 2024.

Pharmacy 52

Pharmacy Marketing Drugs 52

Drug Channels

NOVEMBER 28, 2023

In this issue: A reality check on Express Scripts’ purported “cost-based” pharmacy network Mark Cuban explains how and why the PBM market will change Why two drug prices are better than one Pharmacists sing the retail pharmacy shakeout blues Plus, two Philly legends meet at a cardiology conference! I’m not posting to Threads yet.)

Pharmacy 97

Pharmacy Drugs Marketing 97

Drug Channels

MAY 23, 2023

Below, you’ll find Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share based on equivalent prescription claims. In the meantime, tune in for more PBM-bashing at today's House hearing: The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part I: Self-Interest or Health Care?

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

JUNE 23, 2023

This week, I’m rerunning some popular posts while I prepare for today’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. Below I examine the latest data on pharmacy benefits: cost sharing tier structures, copayment vs. coinsurance, and out-of-pocket obligations.

Pharmacy 98

Pharmacy Drugs 98

Drug Channels

NOVEMBER 15, 2022

The rise of discount card pricing within pharmacy benefit plans is a positive development. However, I suspect few people understand that placing discount cards within the pharmacy benefit enables a PBM to monetize a new fee stream from the card vendor. Links below. to 1:30 p.m.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

JULY 27, 2022

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. To complement that broader ranking, we present below our exclusive and updated list of the top 15 pharmacies based on specialty drug dispensing revenues in 2021.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Drugs 98

Drug Channels

DECEMBER 12, 2022

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2023. During Friday’s webinar, I’ll be sharing my updated thoughts about the IRA’s impact on manufacturers, Part D plans, and patient behavior. Click here to see the original post and comments from September 2022.

Biosimilars 98

Biosimilars Pharmacy Hospitals Marketing 98

Drug Channels

DECEMBER 15, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. Charlotte Morabito at CNBC has put together “Why Pharmacies Overcharge,” an entertaining and provocative video on the pharmacy industry and its generic prescription pricing. Links below.

Pharmacy 98

Pharmacy Drugs 98

Perficient: Drug Development

FEBRUARY 13, 2024

Learn about Adobe’s commitment to maintaining HIPAA-ready standards within commerce solutions and join Perficient and Adobe for a webinar hosted by CMSWire. EST Secure Digital Conversion: Unveiling Adobe’s HIPAA-Ready Commerce Solution webinar hosted by CMSWire. 3 Ways Adobe Commerce Elevates Pharmacy Services

Pharmacy 52

Pharmacy Regulations Science Marketing 52

Drug Channels

JULY 20, 2022

In this issue: CVS disassociates itself from its chain pharmacy association Payers are paying attention to ICER Benefits of the biosimilar boom A fantastic takedown of health insurance deductibles Plus, I join the Advisory Board of Alto Pharmacy. Cut through the steamy summer haze with our refreshing selection of articles and insights.

Biosimilars 98

Biosimilars Pharmacy Drugs Marketing 98

Drug Channels

NOVEMBER 30, 2021

ICYMI, CVS Health recently announced that it will close about 900 of its retail pharmacies. The pharmacy shakeout is accelerating, as smaller competitors exit and larger companies reduce store count. The pharmacy shakeout is accelerating, as smaller competitors exit and larger companies reduce store count.

Pharmacy 98

Pharmacy Drugs 98

Drug Channels

JULY 25, 2022

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. Consider Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share, shown in the chart below.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

SEPTEMBER 23, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Update: Buy-and-Bill Market Trends. I was struck by how quickly Cigna’s Express Scripts PBM business has increased revenues and prescriptions from its retail pharmacy network. Links below.

Pharmacy 97

Pharmacy Marketing Drugs 97

Drug Channels

APRIL 5, 2022

Consider Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share, shown in the chart below. To get a handle on this complex market, join me on April 22 for a new live video webinar, PBM Industry Update: Trends, Controversies, and Outlook.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

NOVEMBER 18, 2021

In my previous post , I highlighted the largest pharmacy chains that will participate in the 2022 Medicare Part D prescription drug plans (PDP). Smaller pharmacies’ rejection of Part D preferred networks shows that they are figuring out how to survive a highly challenging retail environment. Perhaps Part D is just a flesh wound?

Pharmacy 75

Pharmacy Drugs 75

Drug Channels

MAY 2, 2023

In my most recent video webinar , I explored how the rapid expansion of patient-paid prescriptions—via cash-pay pharmacies and discount card vendors—is transforming the prescription market. retail pharmacy pricing. retail pharmacy pricing. Pharmacies and Pharmacy Benefit Managers. and 12.4.3.

Pharmacy 97

Pharmacy Marketing Drugs 97

Drug Channels

NOVEMBER 15, 2021

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2022. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. The Outlook 2022 marks our third annual outlook webinar. Broadcast live on December 17, 2021.

Specialty Pharmacies 94

Specialty Pharmacies Biosimilars Pharmacy Drugs 94

FDA Law Blog: Biosimilars

SEPTEMBER 12, 2023

More than 40 registrants — primarily hospitals and pharmacies — have paid significant civil penalties of up to $5,000,000 to settle allegations they failed to report controlled substance thefts or significant losses to the Drug Enforcement Administration (DEA). The risks to hospitals and pharmacies are multi-faceted and growing.

Hospitals 49

Hospitals Pharmacy Compliance Government 49